Incidence and Descriptive Epidemiology of Mesothelioma in the United States, 1999–2002

References

• Berry G, de Klerk NH, Reid A., et al Malignant pleural and peri-toneal mesotheliomas in former miners and millers of crocido-lite at Wittenoom, Western Australia. Occup Environ Med. 2004; 61: e14.
   PubMed Web of Science ®Google Scholar
• Richards WG, Zellos L, Bueno R., et al Phase I to II study of pleurectomy/decortication and intraoperatiye intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol. 2006; 24: 1561–7.
   PubMed Web of Science ®Google Scholar
• Sugarbaker DJ, Strauss GM, Lynch TJ., et al Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol. 1993; 11: 1172–8.
   PubMed Web of Science ®Google Scholar
• Grondin SC, Sugarbaker DJ. Malignant mesothelioma of the pleural space. Oncology (Williston Park). 1999; 13: 919–26.
   PubMed Web of Science ®Google Scholar
• Lin RR-TT. Ecological association between asbestos-related dis-eases and historical asbestos consumption: an international analysis. Lancet. 2007; 369 (9564): 844–9.
   PubMed Web of Science ®Google Scholar
• Murayama T, Takahashi K, Natori Y, Kurumatani N. Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. Am J Ind Med. 2006; 49: 1–7.
   PubMed Web of Science ®Google Scholar
• Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J. Theexpected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer. 2005; 92: 587–93.
   PubMed Web of Science ®Google Scholar
• Price B, Ware A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol. 2004; 159: 107–12.
   PubMed Web of Science ®Google Scholar
• Weill H, Hughes J, Churg A. Changing trends in US mesothe-lioma incidence. Occup Environ Med. 2005; 62: 270.
   PubMed Web of Science ®Google Scholar
• Bueno R, Gordon GJ. Genetics of malignant pleural mesothe-lioma: molecular markers and biologic targets. Thorac Surg Clin. 2004; 14: 461–8.
   PubMedGoogle Scholar
• Britton M. The epidemiology of mesothelioma. Semin Oncol. 2002; 29: 18–25.
   PubMed Web of Science ®Google Scholar
• Stewart DJ, Edwards JG, Smythe WR, Waller DA, O'Byrne KJ. Malignant pleural mesothelioma-an update. Int J Occup Envi-ron Health. 2004; 10: 26–39.
   PubMed Web of Science ®Google Scholar
• Peto J, Decarli A, La VC, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer. 1999; 79: 666–72.
   PubMed Web of Science ®Google Scholar
• Kukreja J, Jaklitsch MT, Wiener DC, Sugarbaker DJ, Burgers S, Baas P. Malignant pleural mesothelioma: overview of the North American and European experience. Thorac Surg Clin. 2004; 14: 435–45.
   PubMedGoogle Scholar
• Leigh J. Malignant mesothelioma in Australia, 1945-2002. Int J Occup Environ Health. 2003; 9: 206–17.
   PubMed Web of Science ®Google Scholar
• U.S. Cancer Statistics Working Group. United States Cancer Sta-tistics: 2002 Incidence and Mortality. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2005.
   Google Scholar
• Fritz A, Percy C, Jack A., et al International Classification of Dis-eases for Oncology. Third Edition. Geneva, Switzerland: World Health Organization, 2000.
   Google Scholar
• SEER Site Recode ICD-0-3 (1/27/2003) Definition. http://seer.cancer.goy/siterecode/icdo3_d01272003/. Accessed 4/27/20073.
   Google Scholar
• Surveillance Research Program, National Cancer Institute. SEER*Stat software (seer.cancer.goy/seerstat) version 6.2. [computer program]. 2006.
   Google Scholar
• Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution 123. Stat Med. 1997; 16: 791–801.
   PubMed Web of Science ®Google Scholar
• United States Cancer Statistics: 1999-2003 WOD. United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2006.
   Google Scholar
• Kjaergaard J, Andersson M. Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men. Scand J Work Environ Health. 2000; 26: 112–7.
   PubMed Web of Science ®Google Scholar
• Bang KM, Pinheiro GA, Wood J, Syamlal G. Malignant mesothe-lioma mortality in the United States, 1999-2001. Int J Occup Environ Health. 2006; 12: 9–15.
   PubMed Web of Science ®Google Scholar
• Davis LK. Use of death certificates for mesothelioma surveil-lance. Public Health Rep. 1992; 107: 481–3.
   PubMed Web of Science ®Google Scholar
• Pinheiro GA. Malignant mesothelioma surveillance: a compari-son of ICD 10 mortality data with SEER incidence data in nine areas of the United States. Int J Occup Environ Health. 2004; 10: 251–5.
   PubMed Web of Science ®Google Scholar
• Camidge DR. Factors affecting the mesothelioma detection rate within national and international epidemiological studies: insights from Scottish linked cancer registry-mortality data. The BrJ Cancer. 2006; 95: 649–52.
   PubMed Web of Science ®Google Scholar
• Hemminki K, Li X. Time trends and occupational risk factors for peritoneal mesothelioma in Sweden. J Occup Environ Med. 2003; 45: 451–5.
   PubMed Web of Science ®Google Scholar
• Neumann V, Rutten A, Scharmach M, Muller KM, Fischer M. Factors influencing long-term survival in mesothelioma patients-results of the German mesothelioma register. Int Arch Occup Environ Health. 2004; 77: 191–9.
   PubMed Web of Science ®Google Scholar
• Leigh J. Malignant mesothelioma in Australia, 1945-2000. Am J Ind Med. 2002; 41: 188–201.
   PubMed Web of Science ®Google Scholar
• Cooper SP, Fraire AE, Buffler PA, Greenberg SD, Langston C. Epidemiologic aspects of childhood mesothelioma. Pathol Immunopathol Res. 1989; 8: 276–86.
   PubMedGoogle Scholar
• Virta R. Worldwide asbestos supply and consumption trends from 1900 through 2003: U.S. Geological Survey Circular 1298. 2006. !http://pubs.er.usgs.goy/usgspubs/cir/cir1298. Accessed 5/18/2007.
   Google Scholar